These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 32835772)
1. ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation. Foster AD; Downing P; Figredo E; Polain N; Stott A; Layfield R; Rea SL Mol Cell Neurosci; 2020 Oct; 108():103539. PubMed ID: 32835772 [TBL] [Abstract][Full Text] [Related]
2. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. Deng Z; Lim J; Wang Q; Purtell K; Wu S; Palomo GM; Tan H; Manfredi G; Zhao Y; Peng J; Hu B; Chen S; Yue Z Autophagy; 2020 May; 16(5):917-931. PubMed ID: 31362587 [TBL] [Abstract][Full Text] [Related]
3. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62. Foster A; Scott D; Layfield R; Rea SL Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537 [TBL] [Abstract][Full Text] [Related]
4. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies. Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171 [TBL] [Abstract][Full Text] [Related]
6. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Goode A; Rea S; Sultana M; Shaw B; Searle MS; Layfield R Mol Cell Neurosci; 2016 Oct; 76():52-58. PubMed ID: 27554286 [TBL] [Abstract][Full Text] [Related]
7. Functional and structural consequences of TBK1 missense variants in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Gurfinkel Y; Polain N; Sonar K; Nice P; Mancera RL; Rea SL Neurobiol Dis; 2022 Nov; 174():105859. PubMed ID: 36113750 [TBL] [Abstract][Full Text] [Related]
8. Phase-separated protein droplets of amyotrophic lateral sclerosis-associated p62/SQSTM1 mutants show reduced inner fluidity. Faruk MO; Ichimura Y; Kageyama S; Komatsu-Hirota S; El-Gowily AH; Sou YS; Koike M; Noda NN; Komatsu M J Biol Chem; 2021 Dec; 297(6):101405. PubMed ID: 34774801 [TBL] [Abstract][Full Text] [Related]
9. SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD. Rea SL; Majcher V; Searle MS; Layfield R Exp Cell Res; 2014 Jul; 325(1):27-37. PubMed ID: 24486447 [TBL] [Abstract][Full Text] [Related]
10. ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy. Harding O; Evans CS; Ye J; Cheung J; Maniatis T; Holzbaur ELF Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34099552 [TBL] [Abstract][Full Text] [Related]
11. Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice. Duan W; Guo M; Yi L; Zhang J; Bi Y; Liu Y; Li Y; Li Z; Ma Y; Zhang G; Liu Y; Song X; Li C Aging (Albany NY); 2019 Apr; 11(8):2457-2476. PubMed ID: 31039129 [TBL] [Abstract][Full Text] [Related]
12. TRIM27 is an autophagy substrate facilitating mitochondria clustering and mitophagy via phosphorylated TBK1. Garcia-Garcia J; Berge AKM; Overå KS; Larsen KB; Bhujabal Z; Brech A; Abudu YP; Lamark T; Johansen T; Sjøttem E FEBS J; 2023 Feb; 290(4):1096-1116. PubMed ID: 36111389 [TBL] [Abstract][Full Text] [Related]
13. Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Goode A; Butler K; Long J; Cavey J; Scott D; Shaw B; Sollenberger J; Gell C; Johansen T; Oldham NJ; Searle MS; Layfield R Autophagy; 2016 Jul; 12(7):1094-104. PubMed ID: 27158844 [TBL] [Abstract][Full Text] [Related]
14. TBK1: a new player in ALS linking autophagy and neuroinflammation. Oakes JA; Davies MC; Collins MO Mol Brain; 2017 Feb; 10(1):5. PubMed ID: 28148298 [TBL] [Abstract][Full Text] [Related]
15. TBK1 variants in Chinese patients with amyotrophic lateral sclerosis. Liu X; He J; Chen L; Zhang N; Tang L; Liu X; Ma Y; Fan D Neurobiol Aging; 2021 Jan; 97():149.e9-149.e15. PubMed ID: 32893041 [TBL] [Abstract][Full Text] [Related]
16. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway. Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636 [TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis. Kim HC; Zhang Y; King PH; Lu L J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420 [TBL] [Abstract][Full Text] [Related]
20. Functional Characterization of a Familial ALS-Associated Missense Porras G; Ruiz S; Maestro I; Borrego-Hernández D; Redondo AG; Martínez A; Martín-Requero Á Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]